![Subtyping of microsatellite instability-high colorectal cancer | Cell Communication and Signaling | Full Text Subtyping of microsatellite instability-high colorectal cancer | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-019-0397-4/MediaObjects/12964_2019_397_Figa_HTML.png)
Subtyping of microsatellite instability-high colorectal cancer | Cell Communication and Signaling | Full Text
![Summary diagram relating colorectal pathogenesis that may be modulated... | Download Scientific Diagram Summary diagram relating colorectal pathogenesis that may be modulated... | Download Scientific Diagram](https://www.researchgate.net/publication/274395881/figure/fig4/AS:614025536733200@1523406504735/Summary-diagram-relating-colorectal-pathogenesis-that-may-be-modulated-by-EMAST.png)
Summary diagram relating colorectal pathogenesis that may be modulated... | Download Scientific Diagram
![Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761316300644-fx1.jpg)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect
![A) The expression levels of MSI-high, MSI-low and MSS in colorectal... | Download Scientific Diagram A) The expression levels of MSI-high, MSI-low and MSS in colorectal... | Download Scientific Diagram](https://www.researchgate.net/publication/350083406/figure/fig1/AS:1005283899887619@1616689767943/A-The-expression-levels-of-MSI-high-MSI-low-and-MSS-in-colorectal-cancer-patients-B.png)
A) The expression levels of MSI-high, MSI-low and MSS in colorectal... | Download Scientific Diagram
![Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities](https://www.frontiersin.org/files/Articles/795972/fimmu-13-795972-HTML/image_m/fimmu-13-795972-g001.jpg)
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
CCIs in colon cancer with MSS and MSI. The directions and number of... | Download Scientific Diagram
![The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer](https://www.jcancer.org/v08/p2809/jcav08p2809g001.jpg)
The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
![A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ](https://www.spandidos-publications.com/article_images/ol/18/6/ol-18-06-5977-g00.jpg)
A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ
![Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study - eClinicalMedicine Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/b5a1e3c3-c8e4-4f31-a8e9-6c7c295b91f8/gr1.jpg)
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study - eClinicalMedicine
![Frontiers | Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer Frontiers | Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer](https://www.frontiersin.org/files/Articles/508013/fimmu-11-00369-HTML/image_m/fimmu-11-00369-g001.jpg)
Frontiers | Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
![IJMS | Free Full-Text | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment IJMS | Free Full-Text | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment](https://www.mdpi.com/ijms/ijms-17-01030/article_deploy/html/images/ijms-17-01030-g001.png)
IJMS | Free Full-Text | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
![Optimizing Immunotherapy Combinations in Mismatch Repair–Proficient/Microsatellite-Stable Metastatic Colorectal Cancer Optimizing Immunotherapy Combinations in Mismatch Repair–Proficient/Microsatellite-Stable Metastatic Colorectal Cancer](https://dailynews.ascopubs.org/do/10.1200/ADN.22.200821/full/dn22_ee_chau_table-rev-1650522693550.png)
Optimizing Immunotherapy Combinations in Mismatch Repair–Proficient/Microsatellite-Stable Metastatic Colorectal Cancer
![Recent developments in the treatment of metastatic colorectal cancer - Jonathan M. Loree, Scott Kopetz, 2017 Recent developments in the treatment of metastatic colorectal cancer - Jonathan M. Loree, Scott Kopetz, 2017](https://journals.sagepub.com/cms/10.1177/1758834017714997/asset/images/large/10.1177_1758834017714997-fig4.jpeg)
Recent developments in the treatment of metastatic colorectal cancer - Jonathan M. Loree, Scott Kopetz, 2017
![Cancers | Free Full-Text | Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer Cancers | Free Full-Text | Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer](https://www.mdpi.com/cancers/cancers-13-06311/article_deploy/html/images/cancers-13-06311-g001.png)
Cancers | Free Full-Text | Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
![Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells](https://coloproctol.org/upload//thumbnails/ac-32-58-i003.jpg)
Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells
![Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study](https://www.jcancer.org/v13/p2912/toc.jpg)
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
![Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer](https://www.futuremedicine.com/cms/10.2217/crc.14.25/asset/images/medium/figure2.gif)